بدائل البحث:
marked decrease » marked increase (توسيع البحث)
e decrease » we decrease (توسيع البحث), _ decrease (توسيع البحث), a decrease (توسيع البحث)
ct larger » _ larger (توسيع البحث), c large (توسيع البحث)
a marked » _ marked (توسيع البحث), a marker (توسيع البحث), a market (توسيع البحث)
marked decrease » marked increase (توسيع البحث)
e decrease » we decrease (توسيع البحث), _ decrease (توسيع البحث), a decrease (توسيع البحث)
ct larger » _ larger (توسيع البحث), c large (توسيع البحث)
a marked » _ marked (توسيع البحث), a marker (توسيع البحث), a market (توسيع البحث)
-
1
-
2
-
3
Repetitive stress induces a decrease in sound-evoked activity.
منشور في 2025"…<p>(a) Left: noise-evoked activity rates at different noise intensities for chronically tracked PPys cells in baseline and repeated stress conditions (<i>N</i> = 5 mice, <i>n</i> = 285 neurons, mean ± SE). …"
-
4
-
5
-
6
-
7
-
8
-
9
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
منشور في 2025"…Bar graphs depicted EVO increased mRNA expression of (D) SM22α and decreased (E) RUNX2 in CER treated P<sub>i</sub>-induced VSMCs. …"
-
10
Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients.
منشور في 2025"…<b>(D)</b> The Spectral Exponent (0.5–20 Hz) was significantly more negative in the disconnected than in the contralateral cortex, in the session before surgery (Pre) and, particularly, in the session after surgery (Post), whereby consistent inter-hemispheric asymmetry was observed in all patients. <b>(E)</b> Following surgery, the PSD became steeper in the disconnected cortex, as indexed by a significant pre- to post-decrease in Spectral Exponent toward more negative values, observed in all patients (i.e., all negative post-pre differences for the disconnected cortex). …"
-
11
-
12
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
منشور في 2025"…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …"
-
13
-
14
-
15
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
منشور في 2024"…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …"
-
16
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
منشور في 2024"…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …"
-
17
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
منشور في 2024"…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …"
-
18
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
منشور في 2024"…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …"
-
19
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
منشور في 2024"…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …"
-
20